Using tetracyclines to treat osteoporotic/osteopenic bone loss: From the basic science laboratory to the clinic

Pharmacological Research

Volumn 63, Issue 2, 2011, Pages 121-129

  Payne, Jeffrey B ^a   Golub, Lorne M ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Collagenases; Osteopenia; Osteoporosis; Periodontitis; Postmenopausal women; Subantimicrobial dose doxycycline

Indexed keywords

C REACTIVE PROTEIN; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; DOXYCYCLINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUTROPHIL COLLAGENASE; PLACEBO; TETRACYCLINE DERIVATIVE;

ACNE; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; BONE MASS; DRUG APPROVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GINGIVITIS; HUMAN; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PERIODONTITIS; PILOT STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RASH; ROSACEA; SKIN PRURITUS; TOOTH RADIOGRAPHY; TRANSLATIONAL RESEARCH;

ALVEOLAR BONE LOSS; DOXYCYCLINE; FEMALE; FORECASTING; HUMANS; MULTICENTER STUDIES AS TOPIC; OFF-LABEL USE; OSTEOPOROSIS, POSTMENOPAUSAL; PERIODONTITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TETRACYCLINES;

EID: 79251609692     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.10.006     Document Type: Article

References (57)

1. L.M. Golub, H.M. Lee, G. Lehrer, A. Nemiroff, T.F. McNamara, and R. Kaplan Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action J Periodontal Res 18 1983 516 526
2. J.G. Caton, S.G. Ciancio, T.M. Blieden, M. Bradshaw, R.J. Crout, and A.F. Hefti Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis J Periodontol 71 2000 521 532
3. J.B. Payne, and R.A. Reinhardt Potential application of low-dose doxycycline to treat periodontitis in postmenopausal women Adv Dent Res 12 1998 166 169
4. J.R. O'Dell, J.R. Elliott, J.A. Mallek, T.R. Mikuls, C.A. Weaver, and S. Glickstein Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone Arthritis Rheum 54 2006 621 627
5. B.L. Lokeshwar, M.G. Selzer, B.Q. Zhu, N.L. Block, and L.M. Golub Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model Int J Cancer 98 2002 297 309
6. L.M. Golub, K. Suomalainen, and T. Sorsa Host modulation with tetracyclines and their chemically modified analogues Curr Opin Dent 2 1992 80 90
7. W. Xiong, R.A. Knispel, H.C. Dietz, F. Ramirez, and B.T. Baxter Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome J Vasc Surg 47 2008 166 172
8. J. Sanchez, A.L. Somolinos, P.I. Almodovar, G. Webster, M. Bradshaw, and C. Powala A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea J Am Acad Dermatol 53 2005 791 797
9. D.L. Brown, K.K. Desai, B.A. Vakili, C. Nouneh, H.M. Lee, and L.M. Golub Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial Arterioscler Thromb Vasc Biol 24 2004 733 738
10. B.C. Gomes, L.M. Golub, and N.S. Ramamurthy Tetracyclines inhibit parathyroid hormone-induced bone resorption in organ culture Experientia 40 1984 1273 1275
11. T. Sasaki, N. Ohyori, K. Debari, N.S. Ramamurthy, and L.M. Golub Effects of chemically modified tetracycline, CMT-8, on bone loss and osteoclast structure and function in osteoporotic states Ann NY Acad Sci 878 1999 347 360
12. L.M. Golub, R.T. Evans, T.F. McNamara, H.M. Lee, and N.S. Ramamurthy A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats Ann NY Acad Sci 732 1994 96 111
13. N.S. Ramamurthy, B.R. Rifkin, R.A. Greenwald, J.W. Xu, Y. Liu, and G. Turner Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines J Periodontol 73 2002 726 734
14. S. Bain, N.S. Ramamurthy, T. Impeduglia, S. Scolman, L.M. Golub, and C. Rubin Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats Bone 21 1997 147 153
15. R.G. Craig, Z. Yu, L. Xu, R. Barr, N. Ramamurthy, and J. Boland A chemically modified tetracycline inhibits streptozotocin-induced diabetic depression of skin collagen synthesis and steady-state type I procollagen mRNA Biochim Biophys Acta 1402 1998 250 260
16. T. Sasaki, N.S. Ramamurthy, and L.M. Golub Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocin-induced diabetic rats: a quantitative autoradiographic study Calcif Tissue Int 50 1992 411 419
17. L.M. Golub, N.S. Ramamurthy, A. Llavaneras, M.E. Ryan, H.M. Lee, and Y. Liu A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats Ann NY Acad Sci 878 1999 290 310
18. L.M. Golub, H.M. Lee, M.E. Ryan, W.V. Giannobile, J. Payne, and T. Sorsa Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms Adv Dent Res 12 1998 12 26
19. G.F. Nieman, and B.R. Zerler A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury Curr Med Chem 8 2001 317 325
20. R.J. Crout, H.M. Lee, K. Schroeder, H. Crout, N.S. Ramamurthy, and M. Wiener The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study J Periodontol 67 1996 506 514
21. H.M. Lee, L.M. Golub, D. Chan, M. Leung, K. Schroeder, and M. Wolff alpha 1-Proteinase inhibitor in gingival crevicular fluid of humans with adult periodontitis: serpinolytic inhibition by doxycycline J Periodontal Res 32 1997 9 19
22. S. Williams, A. Wakisaka, Q.Q. Zeng, J. Barnes, G. Martin, and W.J. Wechter Minocycline prevents the decrease in BMD and trabecular bone in ovariectomized aged rats Bone 19 1996 637 644
23. J.B. Payne, R.A. Reinhardt, P.V. Nummikoski, and K.D. Patil Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women Osteoporos Int 10 1999 34 40
24. R.A. Reinhardt, J.B. Payne, C.A. Maze, K.D. Patil, S.J. Gallagher, and J.S. Mattson Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women J Periodontol 70 1999 823 828
25. M. Tezal, J. Wactawski-Wende, S.G. Grossi, A.W. Ho, R. Dunford, and R.J. Genco The relationship between bone mineral density and periodontitis in postmenopausal women J Periodontol 71 2000 1492 1498
26. K. Inagaki, Y. Kurosu, N. Yoshinari, T. Noguchi, E.A. Krall, and R.I. Garcia Efficacy of periodontal disease and tooth loss to screen for low bone mineral density in Japanese women Calcif Tissue Int 77 2005 9 14
27. J.B. Payne, R.A. Reinhardt, P.V. Nummikoski, and L.M. Golub Doxycycline effects on oral bone loss in postmenopausal women J Dent Res 80 2001 (special issue A: abstract number 159)
28. J.M. Goodson, A.C. Tanner, A.D. Haffajee, G.C. Sornberger, and S.S. Socransky Patterns of progression and regression of advanced destructive periodontal disease J Clin Periodontol 9 1982 472 481
29. R.A. Reinhardt, J.A. Stoner, L.M. Golub, M.S. Wolff, H.M. Lee, and T.A. Meinberg Efficacy of sub-antimicrobial dose doxycycline in postmenopausal women: clinical outcomes J Clin Periodontol 34 2007 768 775
30. J.B. Payne, J.A. Stoner, P.V. Nummikoski, R.A. Reinhardt, A.D. Goren, and M.S. Wolff Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women J Clin Periodontol 34 2007 776 787
31. A. Solomon, M. Rosenblatt, D.Q. Li, Z. Liu, D. Monroy, and Z. Ji Doxycycline inhibition of interleukin-1 in the corneal epithelium Invest Ophthalmol Vis Sci 41 2000 2544 2557
32. K. Kirkwood, T. Martin, S.T. Andreadis, and Y.J. Kim Chemically modified tetracyclines selectively inhibit IL-6 expression in osteoblasts by decreasing mRNA stability Biochem Pharmacol 66 2003 1809 1819
33. Y. Gu, H.M. Lee, T. Sorsa, S.R. Simon, and L.M. Golub Doxycycline inhibits mononuclear cell-mediated connective tissue breakdown FEMS Immunol Med Microbiol 58 2010 218 225
34. North American Menopause and Society The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society Menopause 13 2006 862 877
35. L.M. Golub, H.M. Lee, J.A. Stoner, T. Sorsa, R.A. Reinhardt, and M.S. Wolff Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women J Periodontol 79 2008 1409 1418
36. T. Sorsa, and L.M. Golub Is the excessive inhibition of matrix metalloproteinases (MMPs) by potent synthetic MMP inhibitors (MMPIs) desirable in periodontitis and other inflammatory diseases? That is: 'Leaky' MMPIs vs. excessively efficient drugs Oral Dis 11 2005 408 409
37. L.M. Golub, H.M. Lee, J.A. Stoner, R.A. Reinhardt, T. Sorsa, and A.D. Goren Doxycycline effects on serum bone biomarkers in postmenopausal women J Dent Res 89 2010 644 649
38. L.M. Golub, H.M. Lee, R.A. Greenwald, M.E. Ryan, T. Sorsa, and T. Salo A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis Inflamm Res 46 1997 310 319
39. K.L. Kirkwood, L.M. Golub, and P.G. Bradford Non-antimicrobial and antimicrobial tetracyclines inhibit IL-6 expression in murine osteoblasts Ann NY Acad Sci 878 1999 667 670
40. T. Kawai, T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, and N.Y. Karimbux B and T lymphocytes are the primary source of RANKL in the bone resorptive lesion of periodontal disease Am J Pathol 169 2006 987 998
41. W.J. Boyle, W.S. Simonet, and D.L. Lacey Osteoclast differentiation and activation Nature 423 2003 337 342
42. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843 (Pubitemid 30165206)
43. B.J. Kim, Y.M. Yu, E.N. Kim, Y.E. Chung, J.M. Koh, and G.S. Kim Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women Clin Endocrinol 67 2007 152 158
44. Payne JB, Stoner JA, Lee HM, Golub LM. Subantimicrobial-dose-doxycycline effects on serum inflammatory biomarkers in postmenopausal-osteopenic-women with periodontitis. J Dent Res 2009;88 (special issue A: abstract number 2916).
45. M. Rees, and J. Stevenson Primary prevention of coronary heart disease in women Menopause Int 14 2008 40 45
46. K.D. McKeage, and E.D. Deeks Doxycycline 40 mg capsules (30 mg immediate-release/10 mg delayed-release beads): anti-inflammatory dose in rosacea Am J Clin Dermatol 11 2010 217 222
47. R. Skidmore, R. Kovach, C. Walker, J. Thomas, M. Bradshaw, and J. Leyden Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne Arch Dermatol 139 2003 459 464
48. C. Walker, S. Puumala, L.M. Golub, J.A. Stoner, R.A. Reinhardt, and H.M. Lee Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results J Periodontol 78 2007 1590 1601
49. S. Renvert, O. Ohlsson, T. Pettersson, and G.R. Persson Periodontitis: a future risk of acute coronary syndrome? A follow-up study over three years J Periodontol 81 2010 992 1000
50. L.M. Golub, N.S. Ramamurthy, T.F. McNamara, R.A. Greenwald, and B.R. Rifkin Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs Crit Rev Oral Biol Med 2 1991 297 321
51. Y. Liu, N. Ramamurthy, J. Marecek, H.M. Lee, J.L. Chen, and M.E. Ryan The lipophilicity, pharmacokinetics, and cellular uptake of different chemically modified tetracyclines (CMTs) Curr Med Chem 8 2001 243 252
52. M.A. Rudek, W.D. Figg, V. Dyer, W. Dahut, M.L. Turner, and S.M. Steinberg Phase I clinical trial of oral COL-3, a matrix-metalloproteinase inhibitor, in patients with refractory metastatic cancer J Clin Oncol 19 2001 584 592
53. B.J. Dezube, S.E. Krown, J.Y. Lee, K.S. Bauer, and D.M. Aboulafia Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS malignancy consortium study J Clin Oncol 24 2006 1389 1394
54. M.E. Ryan, H.M. Lee, R. Tenzler, O.I. Carnu, S. Eftekhari, and A. Dhami Effects of short-term COL-3 on local biomarkers of periodontitis J Dent Res 87 special issue A: abstract number 0040 2008
55. L.M. Golub, H.M. Lee, Y. Zhang, L. London, J. Grewal, and S. Grewal New collagenase (MMP) inhibitors for periodontitis and other diseases J Dent Res 89 special issue B: abstract number 1182 2010
56. J.B. Payne, J.A. Stoner, H.M. Lee, P.V. Nummikoski, R.A. Reinhardt, R. Valente, and L.M. Golub Serum bone-resorption biomarkers: correlation with alveolar and systemic bone changes J Dent Res 87 special issue B: abstract number 1558 2008
57. J.B. Payne, J.A. Stoner, H.M. Lee, P.V. Nummikoski, R.A. Reinhardt, and L.M. Golub Association between serum-bone-formation/bone-turnover biomarkers and alveolar and systemic bone loss J Dent Res 89 special issue A: abstract number 1267 2010